Clinical Characteristics and Outcomes in Patients With Cryptococcaemia From a Large Population-Based Cohort

  • 0Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachusetts, USA.

|

|

Summary

This summary is machine-generated.

Cryptococcus bloodstream infections (BSIs) are deadly, especially in non-HIV patients. Rising fluconazole resistance in Cryptococcus neoformans complex is a growing concern, necessitating ongoing surveillance.

Area Of Science

  • Medical Mycology
  • Infectious Diseases
  • Epidemiology

Background

  • Cryptococcus bloodstream infections (BSIs), or cryptococcaemia, are severe opportunistic infections with high mortality rates.
  • These infections predominantly affect immunocompromised individuals or those with end-stage organ disease.
  • Limited population-based studies exist on infection trends, host factors, geographic variations, antifungal resistance, and clinical outcomes.

Purpose Of The Study

  • To examine trends and identify risk factors associated with mortality in cryptococcaemia over a 20-year period.
  • To investigate the impact of host factors, geography, and antifungal resistance on clinical outcomes.
  • To inform strategies for managing and preventing cryptococcal infections.

Main Methods

  • Retrospective analysis of blood cultures positive for Cryptococcus species from January 1, 2000, to December 31, 2019.
  • Collection and analysis of clinical, microbiological, and outcome data.
  • Survival analyses to determine associations between characteristics and mortality.

Main Results

  • 118 episodes of cryptococcaemia (115 patients) were identified; Cryptococcus neoformans complex caused 98% of infections.
  • Overall 30-day mortality was 34%, significantly higher in non-HIV-associated cases (41.7%) compared to HIV-associated cases (12.5%).
  • Increasing fluconazole minimum inhibitory concentration (MIC) values in C. neoformans complex correlated with increased mortality; 46% of isolates with MIC ≥ 8 mg/L were in the most recent 5-year period.

Conclusions

  • Cryptococcus BSI is highly lethal, particularly in non-HIV infected individuals.
  • Blood culture collection is crucial for diagnosing cryptococcal infections and guiding treatment.
  • Continued surveillance of fluconazole susceptibility is essential due to emerging resistance patterns.

Related Concept Videos

Fungal Phylum Microsporidia 01:28

127

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...

Pulmonary Tuberculosis I 01:29

331

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

COPD: Pathogenesis and Clinical Features 01:20

533

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies 01:27

2.6K

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

• Symptom Review: Chronic symptoms such as persistent cough, sputum production, shortness of breath (dyspnea), and episodes of exacerbation are...

Factors Affecting the Risk of Infection 01:26

12.3K

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

Pneumonia III: Complications and Assessment 01:30

452

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

• Pleurisy: indicates the inflammation of the pleura, which causes chest pain and discomfort.
• Pleural Effusion: indicates fluid buildup in the pleural space.
• Atelectasis: Partial collapse of a lung lobe due to mucus blockage or external compression.
• Bacteremia: Bacterial infection entering the bloodstream, commonly seen with...